The Academy of Managed Care Pharmacy (AMCP) has named former National Association of Chain Drug Stores executive Edith Rosato chief executive officer. She succeeds Judith Cahill, who earlier this year announced that she would be retiring after 16 years as top executive at AMCP.
The people who founded, built and served the chain drug industry in this country during its halcyon days are rapidly disappearing from the scene. During the summer death claimed Charlie Bowlus, the founder and driving force behind ECRM.
Many drug chains can take justifiable pride in their efforts to rethink the shopping experience. Walgreen Co., Rite Aid Corp.
The National Association of Chain Drug Stores has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding its draft federal upper limit (FUL) list.
Though the front end has traditionally been the province of chain drug stores, independent pharmacies are driving sales at a faster rate in six health-related categories, according to a new report from Hamacher Resource Group Inc.
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
The Senate has voted down a measure that would have enabled personal importation of prescription drugs into the United States.
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
The Centers for Medicare & Medicaid Services (CMS) is relying on flawed average manufacturer price (AMP) data to calculate new caps on Medicaid pharmacy reimbursement — known as federal upper limits (FULs) — for multiple-source generic prescription drugs, according to the National Community Pharmac
Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd. The name change is effective immediately, the company said.
Bristol-Myers Squibb Co. has announced some executive moves within its senior management team. The company said Wednesday that Giovanni Caforio has been promoted to president of U.S. Pharmaceuticals. He previously was senior vice president of oncology and immunology global commercialization.
Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.
In recent years homeopathic products have entered many drug store categories, including cold and allergy, baby care, pain relief, feminine care, and ear care.
The at-home diagnostics category is exploding. The category generated more than $190 million in sales in food, drug and mass outlets (excluding Walmart) during the 52 weeks ended May 15, according to SymphonyIRI Group Inc. data.
